Eton Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:ETON) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities 516 K-765 K2.09 M7.96 M12.03 M 21.31 M Cash from investing activities 038.13 M00284 K 38.42 M Cash from financing activities 385 K31.61 M394 K00 32.01 M Free cash flow 516 K-8.9 M2.09 M7.96 M11.74 M 12.89 M

Nachrichten

DESMODA oral solüsyonu diabetes insipidus için FDA onayı aldı

DESMODA oral solution receives FDA approval for diabetes insipidus

Eton Pharmaceuticals hisseleri ultra nadir hastalık ilacının lisanslanmasıyla yükseldi

Eton Pharmaceuticals stock rises after licensing ultra-rare disease drug

Eton Pharmaceuticals ultra nadir hastalık tedavi adayı için lisans aldı

Eton Pharmaceuticals licenses ultra-rare disease treatment candidate

Implied Volatility Surging for Eton Pharmaceuticals Stock Options

Eton Pharmaceuticals, Inc. (ETON) Reports Q3 Loss, Beats Revenue Estimates

Eton Pharmaceuticals kazancı $0,07 ile beklentilere göre daha kötü, kâr ise beklentilere göre yüksek

Eton Pharmaceuticals earnings missed by $0.07, revenue topped estimates

Airbnb, Monster Beverage, Take-Two and more set to report earnings Thursday

Eton Stock Has Focused Growth But Valuation Limits Upside: Why I Choose To Hold